Skip to content
value.today

Merck & Co., Inc. vs Pfizer Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Merck & Co., Inc. is the larger company by market value: $359.8 B against $170.7 B for Pfizer Inc., 2.1 times as much (market caps of Oct 19, 2026 for Merck & Co., Inc. and Oct 30, 2026 for Pfizer Inc.).
  • Merck & Co., Inc. had more revenue: $65.0 B against $62.6 B for Pfizer Inc., both in the year to December 2025.
  • Merck & Co., Inc. earned more: net income of $18.3 B against $7.8 B for Pfizer Inc.
  • Merck & Co., Inc. keeps more of each dollar of sales: a net margin of 28.1% against 12.4% for Pfizer Inc.
  • Both employ 75,000 people. Each employee brings in about $866,813 of revenue at Merck & Co., Inc. and $834,387 at Pfizer Inc.
  • On price to earnings, Merck & Co., Inc. trades at 146.7× and Pfizer Inc. at 42.3×: investors pay more for each dollar of Merck & Co., Inc.'s profit.
  • Merck & Co., Inc.'s revenue grew faster in its latest fiscal year: +1.3% against -1.6% for Pfizer Inc.
  • On the Piotroski F-score, a nine-point test of improving finances, Merck & Co., Inc. scores 4 and Pfizer Inc. 5.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

039781171552020202120222023202420252026Merck & Co., Inc. 155Pfizer Inc. 79

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$25B$51B$76B$101B201720182019202020212022202320242025Merck & Co., Inc. $65BPfizer Inc. $63B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureMerck & Co., Inc.
MRK · #41 in the world
Pfizer Inc.
PFE · #127 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19701849
Size
Market cap$359.8 B$170.7 B
Revenue$65.0 B$62.6 B
Net income$18.3 B▲ best$7.8 B
Employees75,00075,000
Valuation
P/E ratio147×42.3×
Price to sales5.3×2.7×
Price to book6.8×2.0×
Free cash flow yield3.4%5.3%▲ best
Profitability
Gross margin74.8%▲ best74.3%
Net margin28.1%▲ best12.4%
Return on equity36.9%▲ best8.9%
Growth
Revenue growth1.3%▲ best-1.6%
Revenue growth, 3 years a year3.1%▲ best-14.8%
Earnings per share growth8.0%▲ best-3.5%
Financial strength
Debt to equity0.9×0.7×▲ best
Cash
Free cash flow margin19.0%▲ best14.5%
Shareholder returns
Dividend yield2.3%—
Shareholder yield3.7%—
Strength scores
Piotroski F-score4 of 95 of 9▲ best
Altman Z-score zone——
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Merck & Co., Inc. or Pfizer Inc.?

Merck & Co., Inc. is the larger company by market value: $359.8 B against $170.7 B for Pfizer Inc., 2.1 times as much (market caps of Oct 19, 2026 for Merck & Co., Inc. and Oct 30, 2026 for Pfizer Inc.).

Which makes more money, Merck & Co., Inc. or Pfizer Inc.?

Merck & Co., Inc. had more revenue: $65.0 B against $62.6 B for Pfizer Inc., both in the year to December 2025. Merck & Co., Inc. earned more: net income of $18.3 B against $7.8 B for Pfizer Inc.

Which is more profitable, Merck & Co., Inc. or Pfizer Inc.?

Merck & Co., Inc. keeps more of each dollar of sales: a net margin of 28.1% against 12.4% for Pfizer Inc.

Which has more employees, Merck & Co., Inc. or Pfizer Inc.?

Both employ 75,000 people. Each employee brings in about $866,813 of revenue at Merck & Co., Inc. and $834,387 at Pfizer Inc.

Is Merck & Co., Inc. cheaper than Pfizer Inc.?

On price to earnings, Merck & Co., Inc. trades at 146.7× and Pfizer Inc. at 42.3×: investors pay more for each dollar of Merck & Co., Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Which is growing faster, Merck & Co., Inc. or Pfizer Inc.?

Merck & Co., Inc.'s revenue grew faster in its latest fiscal year: +1.3% against -1.6% for Pfizer Inc.

Which is financially stronger, Merck & Co., Inc. or Pfizer Inc.?

On the Piotroski F-score, a nine-point test of improving finances, Merck & Co., Inc. scores 4 and Pfizer Inc. 5.